Sustained treatment‐free remission in chronic myeloid leukaemia is associated with an increased frequency of innate CD8(+) T‐cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sustained treatment‐free remission in chronic myeloid leukaemia is associated with an increased frequency of innate CD8(+) T‐cells

Published:2019-03-12 Issue:1 Volume:186 Page:54-59
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Cayssials Emilie¹²³⁴⁵^ORCID,Jacomet Florence¹³⁴⁶,Piccirilli Nathalie¹³⁴,Lefèvre Lucie¹³,Roy Lydia⁷⁸,Guilhot François⁴⁵,Chomel Jean‐Claude⁹,Leleu Xavier²³⁴⁵,Gombert Jean‐Marc¹³⁴⁵⁶,Herbelin André¹³,Barbarin Alice¹³

Affiliation:

1. INSERM 1082 PoitiersFrance

2. Service d'Oncologie Hématologique de Thérapie Cellulaire CHU de Poitiers PoitiersFrance

3. Université de Poitiers PoitiersFrance

4. CHU de Poitiers PoitiersFrance

5. INSERM CIC‐1402 PoitiersFrance

6. Service d'Immunologie et d'Inflammation CHU de Poitiers PoitiersFrance

7. Service Clinique d'Hématologie Hôpital Henri‐Mondor CreteilFrance

8. Université Paris‐Est Créteil CreteilFrance

9. Service de Cancérologie Biologique CHU de Poitiers Poitiers France

Funder

Institut National de la Santé et de la Recherche Médicale

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.15858

Reference15 articles.

1. Natural Killer Cells: Development, Maturation, and Clinical Utilization

2. NK cells are dysfunctional in human chronic myelogenous leukemia before and on imatinib treatment and in BCR–ABL-positive mice

3. The Tyrosine Kinase Inhibitors Imatinib and Dasatinib Reduce Myeloid Suppressor Cells and Release Effector Lymphocyte Responses

4. Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity

5. Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification and validation of hub genes and molecular classifications associated with chronic myeloid leukemia;Frontiers in Immunology;2024-01-12

2. Second Treatment-Free Remission Attempt in Patients with Chronic Myeloid Leukemia;Clinical Lymphoma Myeloma and Leukemia;2023-12

3. Chronic Myeloid Leukemia, from Pathophysiology to Treatment-Free Remission: A Narrative Literature Review;Journal of Blood Medicine;2023-04

4. Immunomodulatory Activity of the Tyrosine Kinase Inhibitor Dasatinib to Elicit NK Cytotoxicity against Cancer, HIV Infection and Aging;Pharmaceutics;2023-03-11

5. Helminth Infection–Induced Increase in Virtual Memory CD8 T Cells Is Transient, Driven by IL-15, and Absent in Aged Mice;The Journal of Immunology;2023-02-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3